ALERS Statistics
Total Valuation
Eurobio Scientific Société anonyme has a market cap or net worth of EUR 247.58 million. The enterprise value is 259.21 million.
Market Cap | 247.58M |
Enterprise Value | 259.21M |
Important Dates
The next estimated earnings date is Tuesday, September 24, 2024.
Earnings Date | Sep 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Eurobio Scientific Société anonyme has 10.04 million shares outstanding. The number of shares has increased by 0.06% in one year.
Shares Outstanding | 10.04M |
Shares Change (YoY) | +0.06% |
Shares Change (QoQ) | -20.37% |
Owned by Insiders (%) | 0.17% |
Owned by Institutions (%) | 4.96% |
Float | 5.51M |
Valuation Ratios
The trailing PE ratio is 57.33 and the forward PE ratio is 25.95.
PE Ratio | 57.33 |
Forward PE | 25.95 |
PS Ratio | 2.10 |
PB Ratio | 1.41 |
P/FCF Ratio | 10.90 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.65, with an EV/FCF ratio of 11.41.
EV / Earnings | 53.61 |
EV / Sales | 1.98 |
EV / EBITDA | 13.65 |
EV / EBIT | 25.56 |
EV / FCF | 11.41 |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 57.46.
Current Ratio | 2.72 |
Quick Ratio | 2.26 |
Debt / Equity | 57.46 |
Debt / EBITDA | 5.30 |
Debt / FCF | 4.43 |
Interest Coverage | 2.33 |
Financial Efficiency
Return on equity (ROE) is 2.78% and return on invested capital (ROIC) is 2.25%.
Return on Equity (ROE) | 2.78% |
Return on Assets (ROA) | 1.96% |
Return on Capital (ROIC) | 2.25% |
Revenue Per Employee | 435,487 |
Profits Per Employee | 16,117 |
Employee Count | 300 |
Asset Turnover | 0.40 |
Inventory Turnover | 3.67 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.70% in the last 52 weeks. The beta is -0.28, so Eurobio Scientific Société anonyme's price volatility has been lower than the market average.
Beta (5Y) | -0.28 |
52-Week Price Change | -30.70% |
50-Day Moving Average | 19.42 |
200-Day Moving Average | 16.66 |
Relative Strength Index (RSI) | 85.92 |
Average Volume (20 Days) | 21,276 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Eurobio Scientific Société anonyme had revenue of EUR 130.65 million and earned 4.84 million in profits. Earnings per share was 0.43.
Revenue | 130.65M |
Gross Profit | 51.58M |
Operating Income | 10.14M |
Pretax Income | 6.98M |
Net Income | 4.84M |
EBITDA | 18.99M |
EBIT | 10.14M |
Earnings Per Share (EPS) | 0.43 |
Balance Sheet
The company has 89.03 million in cash and 100.66 million in debt, giving a net cash position of -11.63 million or -1.16 per share.
Cash & Cash Equivalents | 89.03M |
Total Debt | 100.66M |
Net Cash | -11.63M |
Net Cash Per Share | -1.16 |
Equity (Book Value) | 175.17M |
Book Value Per Share | 17.44 |
Working Capital | 91.03M |
Cash Flow
In the last 12 months, operating cash flow was 26.77 million and capital expenditures -4.05 million, giving a free cash flow of 22.71 million.
Operating Cash Flow | 26.77M |
Capital Expenditures | -4.05M |
Free Cash Flow | 22.71M |
FCF Per Share | 2.26 |
Margins
Gross margin is 39.48%, with operating and profit margins of 7.76% and 3.70%.
Gross Margin | 39.48% |
Operating Margin | 7.76% |
Pretax Margin | 5.34% |
Profit Margin | 3.70% |
EBITDA Margin | 14.53% |
EBIT Margin | 7.76% |
FCF Margin | 17.39% |
Dividends & Yields
Eurobio Scientific Société anonyme does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.06% |
Shareholder Yield | -0.06% |
Earnings Yield | 1.74% |
FCF Yield | 9.17% |
Stock Splits
The last stock split was on September 1, 2017. It was a reverse split with a ratio of 0.05.
Last Split Date | Sep 1, 2017 |
Split Type | Reverse |
Split Ratio | 0.05 |